The silencing of ISG15 in human hepatoma cells was found to lead to an inhibition of HCV replication, increases in cell sensitivity to IFN-α/β and accumulation of IFN-α/β-stimulated gene products (ISGs). Here, IFNA2 is linked to hepatocellular carcinoma.